The research team is being led by Polly Newcomb, PhD, the head of the center’s cancer prevention program.
“About 20 to 30 percent of all colorectal cancers have this subtype,” said Dr. Newcomb, a longtime public health researcher. “It’s more difficult to find and there’s evidence that these are particularly aggressive cancers. Patients are more likely to have a poorer outcome.”
Dr. Newcomb will work with Fred Hutchinson researchers including gastroenterologist William Grady, MD; epidemiologist Amanda Phipps, PhD and biostatistician Chad He, PhD.
More articles on gastroenterology:
FDA clears 2 new HCV drugs
ACG playbook on CMS colonoscopy cuts: 6 recommendations
FDA approves Coldplay Cryoballoon for Barrett’s esophagus
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
